Original Research
Published on 30 Jun 2017
Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2017.00756
- 5,484 views
- 21 citations
